| ∆ψM | Transmembrane potential |
| 7-AAD | 7-Aminoactinomycin D |
| AF | Auranofin |
| ALL | Acute lymphoblastic leukemia |
| ATP | Adenosine triphosphate |
| BCA | Bicinchoninic acid |
| BRCA2 | Breast cancer type 2 susceptibility protein |
| BZ | Bortezomib |
| CI | Combination index |
| CLL | Chronic lymphocytic leukemia |
| CO2 | Carbon dioxide |
| DEVD | DNA-binding peptide; substrate for caspase-3 |
| DHE | Dihydroethidium |
| DNA | Deoxyribonucleic acid |
| DTNB | 5,5′-dithio-bis (2-nitrobenzoic acid) |
| DTT | Dithiothreitol |
| FBS | Fetal bovine serum |
| FDA | US Food and Drug Administration |
| GLOBOCAN | Global Cancer Observatory |
| GSH | Glutathione |
| H2AX | Histone variant H2AX |
| HCl | Hydrochloric acid |
| HEPES | 4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid |
| HGSOC | High-grade serous ovarian cancer |
| HIV | Human immunodeficiency virus |
| HRP | Horseradish peroxidase |
| IC50 | Half-maximal inhibitory concentration |
| IgG | Immunoglobulin G |
| L-BSO | L-buthionine sulfoximine |
| MTT | 3-(4,5-dimethylliazol-2-yl)-2,5-diphenyltetrazolium bromide |
| NAC | N-acetyl-L-cysteine |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NRF2 | Nuclear factor erythroid 2-related factor 2 |
| NSLC | Non-small cell lung cancer |
| OD | Optical density |
| PARP | Poly-adenosine diphosphate (ADP) ribose polymerase |
| PBS | Phosphate-buffered saline |
| PE | Phycoerythrin |
| P3Cy5 | Phycoerythrin-Cyanine®5 |
| PFA | Paraformaldehyde |
| PMSF | Phenylmethylsulfonyl fluoride |
| PS | Phosphatidylserine |
| ROS | Reactive oxygen species |
| SDS | Sodium dodecyl sulfate |
| TBS-T | Tris-buffered saline 0.1% Tween 20 |
| TNB | 5′-thio-2-nitrobenzoic acid |
| TrxR | Thioredoxin reductase |
| z-DEVD-fmk | Caspase-3 inhibitor |